Efficacy, safety and health-related life quality of chronic myeloid leukemia during the chronic period switching from branded Gleevec or Tasigna to generic imatinib.
10.3760/cma.j.issn.0253-2727.2019.09.011
- Author:
Ting ZHAO
1
;
Lu YU
;
Ya Zhen QIN
;
Xiao Jun HUANG
;
Yue HOU
;
Qian JIANG
Author Information
1. Peking University People's Hospital, Peking University Institute of Hematology, Beijing 100044, China.
- Publication Type:Journal Article
- MeSH:
Drugs, Generic;
Humans;
Imatinib Mesylate/therapeutic use*;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy*;
Pyrimidines/therapeutic use*;
Quality of Life;
Treatment Outcome
- From:
Chinese Journal of Hematology
2019;40(9):764-768
- CountryChina
- Language:Chinese
